Bazedoxifene is a third-generation selective estrogen receptor modulator (SERM) primarily indicated for the prevention and treatment of postmenopausal osteoporosis. Analytical laboratories require comprehensive… Read more





![Chemical structure of 1-[4-(Benzyloxy)-3-bromophenyl]-2-bromopropan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2512198-68-2-1-4-Benzyloxy-3-bromophenyl-2-bromopropan-1-one.png&w=3840&q=75)


















Bazedoxifene is a third-generation selective estrogen receptor modulator (SERM) primarily indicated for the prevention and treatment of postmenopausal osteoporosis. Analytical laboratories require comprehensive sets of reference standards to ensure the rigorous quality control and regulatory compliance of this therapeutic agent. The product list includes the active pharmaceutical ingredient alongside a suite of related compounds essential for pharmaceutical analysis. This collection supports detailed impurity profiling, allowing for the identification and quantification of synthetic impurities, such as specific chloro ketone and benzaldehyde derivatives, as well as degradation products. Furthermore, the availability of major metabolites, including glucuronide conjugates, facilitates metabolic studies. For researchers performing quantitative bioanalysis, stable isotope labelled versions of the drug and its metabolites serve as critical internal standards to improve accuracy and precision during mass spectrometry-based assays, ultimately supporting robust method validation and routine testing procedures.